The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
QUALITY CHOICE Nausea Relief
Sodium Citrate dihydrate · TRISODIUM CITRATE DIHYDRATE 230 mg/1 · Tablet, Chewable · Oral · Quality Choice (Chain Drug Marketing Association)
NDC 83324-0300-42 · 3 BLISTER PACK in 1 CARTON / 14 TABLET, CHEWABLE in 1 BLISTER PACK · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sodium Citrate dihydrate (Tablet, Chewable)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| WellSpring Pharmaceutical Corporation | TRISODIUM CITRATE DIHYDRATE 230 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Cvs Pharmacy,inc. | TRISODIUM CITRATE DIHYDRATE 230 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Quality Choice (Chain Drug Marketing Association) | TRISODIUM CITRATE DIHYDRATE 230 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Walgreens Co. | TRISODIUM CITRATE DIHYDRATE 230 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "QUALITY CHOICE Nausea Relief — NDC 83324-0300-42," retrieved September 3, 2026, https://drugdashboards.com/drug/83324030042.
Free to cite with attribution — see how the data is put together.